Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 20:11:2021-12-3.
doi: 10.7573/dic.2021-12-3. eCollection 2022.

Addressing COVID-19 vaccine hesitancy

George Kassianos  1   2 , Joan Puig-Barberà  3 , Hannah Dinse  4 , Martin Teufel  4 , Özlem Türeci  5 , Shanti Pather  5
Affiliations
Review

Addressing COVID-19 vaccine hesitancy

George Kassianos et al. Drugs Context. .

Abstract

Immunization programmes have been globally recognized as one of the most successful medical interventions against infectious diseases. Despite the proven efficacy and safety profiles of coronavirus disease 2019 (COVID-19) vaccines, there are still a substantial number of people who express vaccine hesitancy. Factors that influence vaccine decision-making are heterogenous, complex, and context specific and may be caused or amplified by uncontrolled online information or misinformation. With respect to COVID-19, the recent emergence of novel variants of concern that give rise to milder disease also drives vaccine hesitancy. Healthcare professionals remain one of the most trusted groups to advise and provide information to those ambivalent about COVID-19 vaccination and should be equipped with adequate resources and information as well as practical guidance to empower them to effectively discuss concerns. This article seeks to summarize the currently available information to address the most common concerns regarding COVID-19 vaccination.

Keywords: COVID-19; SARS-CoV-2; boosters; coronavirus; hesitancy; infectious disease; public health; vaccination.

PubMed Disclaimer

Conflict of interest statement

Disclosure and potential conflicts of interest: HD and MT have nothing to disclose. GK is chairman of the RAISE Pan-European Influenza Group (20 countries), a board member of European Scientific Working Group on Influenza (ESWI), National Immunisation Lead of the Royal College of General Practitioners, and President of the British Global & Travel Health Association; he participated in advisory boards or lectured at meetings organized by MSD, Sanofi Vaccines, Pfizer, Seqirus, AstraZeneca, GSK, Valneva, and Janssen and has lectured at meetings organized by the European Parliament, UK Health Security Agency, and ESWI. JPB has previously received honoraria and/or consulting fees from Seqirus and Sanofi Vaccines. SP and ÖT have received salary support from BioNTech SE. ÖT is a cofounder of BioNTech SE and TRON (Translational Oncology Mainz), holds issued patents with BioNTech SE and TRON, and holds BioNTech SE shares. All authors received medical writing support during drafting of this manuscript. The International Committee of Medical Journal Editors (ICMJE) Potential Conflicts of Interests form for the authors is available for download at: https://www.drugsincontext.com/wp-content/uploads/2022/05/dic.2021-12-3-COI.pdf

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Andre FE, Booy R, Bock HL, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ. 2008;86(2):140–146. https://apps.who.int/iris/handle/10665/270129 . - PMC - PubMed
    1. Pormohammad A, Zarei M, Ghorbani S, et al. Efficacy and safety of COVID-19 vaccines: a systematic review and meta-analysis of randomized clinical trials. Vaccines. 2021;9(5):467. doi: 10.3390/vaccines9050467. - DOI - PMC - PubMed
    1. Morens DM, Folkers GK, Fauci AS. The concept of classical herd immunity may not apply to COVID-19. J Infect Dis. 2022 doi: 10.1093/infdis/jiac109. - DOI - PMC - PubMed
    1. Loomba S, de Figueiredo A, Piatek SJ, deGraaf K, Larson HJ. Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA. Nat Hum Behav. 2021;5(3):337–348. doi: 10.1038/s41562-021-01056-1. - DOI - PubMed
    1. Tenforde MW, Self WH, Adams K, et al. Association between mRNA vaccination and COVID-19 hospitalization and disease severity. JAMA. 2021;326(20):2043–2054. doi: 10.1001/jama.2021.19499. - DOI - PMC - PubMed